| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |